Evaluation of Imatinib adherence in chronic myeloid leukemia patients in Babylon Province, Iraq

Background: Chronic myeloid leukemia is a clonal myeloproliferative neoplasm that results in proliferation, mainly of granulocytic components. Resulting from t(9;22) with fusion oncogen BCR-ABL1 which has uninhibited tyrosine kinase activity. The introduction of tyrosine kinase inhibitors, such as I...

Full description

Bibliographic Details
Main Authors: Athmar Kadhim Gatea, Mohammed Ali Al-Jabory, Noor Hasan Baiee
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2023-01-01
Series:Medical Journal of Babylon
Subjects:
Online Access:http://www.medjbabylon.org/article.asp?issn=1812-156X;year=2023;volume=20;issue=2;spage=388;epage=392;aulast=Gatea